Product Information
SPIRIVA RESPIMAT 1.25 MCG INH is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $126.0828 per GM under NDC 00597016061. Its NADAC has been published 536 times since Mar 23, 2016.
Strength
1.562 ug/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597016061
Classification
Brand
Dosage Form
SPRAY, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
TIOTROPIUM BROMIDE ANHYDROUSApproval Type
New Drug (NDA)
FDA Application
NDA207070On Market Since
9/15/2015
Pharmacological Classes
Price Statistics
The NADAC for SPIRIVA RESPIMAT 1.25 MCG INH has been published 536 times since Mar 23, 2016, and over the history we have for it it has risen 69.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $126.0828 per GM |
|---|---|
| All-time high | $126.3020 (Sep 11, 2024) |
| All-time low | $74.1950 (Mar 23, 2016) |
| 52-week high | $126.2076 |
| 52-week low | $126.0828 |
| Median price | $114.5362 |
| Average price | $110.0080 |
| Largest weekly change | +8.0% (Jan 10, 2018) |
| Weeks tracked | 536 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tiotropium bromide inhalation spray market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SPIRIVA RESPIMAT 1.25 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for SPIRIVA RESPIMAT 1.25 MCG INH, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $126.0828 per GM (NDC 00597016061), effective Jun 24, 2026.
How has the price of SPIRIVA RESPIMAT 1.25 MCG INH changed over time?
Over the history we have for it, the NADAC for SPIRIVA RESPIMAT 1.25 MCG INH has risen 69.9%. It has been tracked across 536 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for SPIRIVA RESPIMAT 1.25 MCG INH?
Since Mar 23, 2016, the NADAC for SPIRIVA RESPIMAT 1.25 MCG INH has ranged from a low of $74.1950 (Mar 23, 2016) to a high of $126.3020 (Sep 11, 2024), with a median of $114.5362 per GM.
Are there cheaper alternatives to SPIRIVA RESPIMAT 1.25 MCG INH?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SPIRIVA RESPIMAT 1.25 MCG INH, so no direct lower-cost alternative is listed.
Who manufactures SPIRIVA RESPIMAT 1.25 MCG INH?
SPIRIVA RESPIMAT 1.25 MCG INH (NDC 00597016061) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification